Clinical Trials List
Protocol NumberD6972C00006
Active
2025-12-01 - 2027-12-31
Phase II
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
Co-Principal Investigator
- 陳靜怡 Division of Nephrology
- Te-Chao Fang Division of Nephrology
- Chih-Chin Kao Division of Nephrology
- I-WEN WU Division of Nephrology
Co-Principal Investigator
- 鄭昌錡 Division of Nephrology
- Ya-Chung Tian Division of Nephrology
- Guan-Hsing Chen Division of Nephrology
- 吳欣旭 Division of Nephrology
- Cheng-Chia Lee Division of Nephrology
- 范佩君 Division of Nephrology
- Yung-Chang Chen Division of Nephrology
- Chih-Shiang Chang Division of Nephrology
Co-Principal Investigator
- 林裕峯 Division of Nephrology
- CHUN-FU LAI Division of Nephrology
- YU-HSIANG CHOU Division of Nephrology
- 陳怡婷 Division of Nephrology
- 潘思宇 Division of Nephrology
- - - Division of Nephrology
- 黃道民 Division of Nephrology
Co-Principal Investigator
- Li-Yee Hong Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- Yu-Wei Chen Division of Nephrology
- 林冠宏 Division of Nephrology
- Chia-Te Liao Division of Nephrology
- 高芷華 Division of Nephrology
Co-Principal Investigator
- 洪啟智 Division of Nephrology
- 李佳蓉 Division of Nephrology
- 郭美娟 Division of Nephrology
- Shang-Jyh Hwang Division of Nephrology
Co-Principal Investigator
- 洪東衛 Division of Nephrology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
64 participants
-
Global
218 participants
